One-Sample Multiple Testing Procedure for Phase II Clinical Trials
Thomas R. Fleming · Biometrics · 1982
Commonly, the central objective of Phase II clinical trials is the assessment of the antitumor 'therapeutic efficacy' of a specific treatment regimen. It is of interest to formulate test procedures which can be employed in these trials to decide whether or not this therapeutic efficacy warrants further investigation. For ethical reasons, these procedures should allow for early termination if initial results are extreme. In this paper, a one-sample multiple testing procedure is proposed which employs the standard single-stage test procedure at the last test, and which both allows for early termination and essentially preserves the size, power and simplicity of the single-stage procedure.
Cited by 1,003 works. doi:10.2307/2530297
Authors
References
- A Multiple Testing Procedure for Clinical Trials
- Group Sequential Methods in the Design and Analysis of Clinical Trials
- Repeated Significance Tests on Accumulating Data
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
- Multiple-Stage Procedures for Drug Screening
- Predictive Probability Early Termination Plans For Phase II Clinical Trials
- Two-stage plans for patient accrual in phase II cancer clinical trials.
- Relationships between Bayesian and Confidence Limits for Predictions
- A Survey of Prediction Intervals and their Applications